Companies In the News
Authors:
Date:
PRNewswire: October 31, 2016 – MISSISSAUGA, Ontario, Canada – Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced that its subsidiary, Aralez Pharmaceuticals Trading DAC (Aralez Ireland), has completed its acquisition of the U.S. rights…
Authors:
Date:
Business Wire: October 26, 2016 – AUSTIN, TX, U.S.A. – Mati Therapeutics, Inc. (“Mati”) announced that it has been granted U.S. patent number 9,445,944 titled “Lacrimal Implants and Related Methods.” The patent, which expires in 2028, claims a method of providing a sustained drug release to an eye…
Authors:
Date:
Business Wire: October 24, 2016 – STOCKHOLM, Sweden – Braeburn Pharmaceuticals and Camurus (STO: CAMX) today announced the expansion of their collaboration and license agreement from 2014 to include buprenorphine combination products. The first drug candidate within the expanded scope (CAM2058) is…
Authors:
Date:
Business Wire: October 13, 2016 – BEDFORD, MA, U.S.A. – Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it has entered into a strategic…
Authors:
Date:
PRNewswire: October 10, 2016 – PHILADELPHIA, PA, U.S.A. – Biopharmaceuticals like insulin have been used for decades in medical practice, but dental medicine has few such drugs and those that are used are delivered invasively, often through gum surgery.
Now, a report in Biomaterials by Penn Dental…
Authors:
Date:
PRNewswire: October 6, 2016 – WARREN, NJ, U.S.A., BALTIMORE, MD, U.S.A., and MUMBAI, India – Lupin Pharmaceutical Inc., the U.S. subsidiary of pharma major Lupin Limited (collectively Lupin), and MonoSol Rx, a specialty pharmaceutical company, have entered into a strategic licensing agreement…
